DSpace Repository

Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study

Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study

Arslan, Ulku Yalcintas; Kaplan, Muhammet Ali; Isikdogan, Abdurrahman; Koca, Dogan; Kucukoner, Mehmet; Gumusay, Ozge; Yildiz, Ramazan; Oztop, Ilhan; Demir, Lutfiye; Geredeli, Caglayan; Kocer, Murat; Inal, Ali; Coskun, Ugur; Sener, Nur; Inanc, Mevlude; Elkiran, Emin Tamer; Ozdemir, Nuriye; Durnali, Ayse Gok; Suner, Ali; Alici, Suleyman
URI: http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/76280

Show full item record

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account